• acetyl
  • The N-terminal amino group of a polypeptide can be modified covalently, e.g., acetylation − C ( = O ) − C H 3 {\displaystyle \mathrm {-C(=O)-CH_{3}} } The positive charge on the N-terminal amino group may be eliminated by changing it to an acetyl group (N-terminal blocking). (wikipedia.org)
  • serine
  • A phosphate group can be attached to the sidechain hydroxyl group of serine, threonine and tyrosine residues, adding a negative charge at that site and producing an unnatural amino acid. (wikipedia.org)
  • Now EC 3.4.15.5, peptidyl-dipeptidase Dcp EC 3.4.15.4: Peptidyl-dipeptidase B EC 3.4.15.5: Peptidyl-dipeptidase Dcp EC 3.4.15.6: cyanophycinase EC 3.4.16.1: Transferred entry: serine carboxypeptidase. (wikipedia.org)
  • Now included with EC 3.4.16.5, carboxypeptidase C EC 3.4.16.4: serine-type D-Ala-D-Ala carboxypeptidase EC 3.4.16.5: carboxypeptidase c EC 3.4.16.6: carboxypeptidase D EC 3.4.17.1: carboxypeptidase A EC 3.4.17.2: carboxypeptidase B EC 3.4.17.3: lysine carboxypeptidase EC 3.4.17.4: Gly-X carboxypeptidase EC 3.4.17.5: Deleted entry: aspartate carboxypeptidase EC 3.4.17.6: alanine carboxypeptidase EC 3.4.17.7: Transferred entry: acylmuramoyl-alanine carboxypeptidase. (wikipedia.org)
  • Now EC 3.4.21.74, venombin A EC 3.4.21.29: Transferred entry: Bothrops atrox serine proteinase. (wikipedia.org)
  • Now EC 3.4.21.74, venombin A EC 3.4.21.30: Transferred entry: Crotalus adamanteus serine proteinase. (wikipedia.org)
  • The NS3 serine protease of HCV is a multifunctional protein which contains a serine protease domain and a RNA helicase domain. (allindianpatents.com)
  • wherein
  • 6. The recombinant solventogenic organism of claim 1, wherein the gene is selected from a gene involved in a pathway selected from the group consisting of solventogenesis, chemotaxis, spore formation and sugar transport. (patentsencyclopedia.com)
  • 9. The recombinant solventogenic organism of claim 8, wherein the gene comprises a nucleotide sequence having at least 80% homology to the sequence selected from the group consisting of Adh (SEQ ID NO: 1), Bcd (SEQ ID NO: 2), and Buk (SEQ ID NO: 3) or complements thereof. (patentsencyclopedia.com)
  • 8. The method of claim 1, wherein the recombinant host cell further has a deficiency in activity of one or more enzymes selected from the group consisting of pyruvate oxidase (poxB), pyruvate-formate lyase (pflB), phosphotransacetylase (pta), acetate kinase (ackA), aldehyde dehydrogenase (aldB), alcohol dehydrogenase (adhE), alcohol dehydrogenase (adhP), methylglyoxal synthase (mgsA), and lactate dehydrogenase (ldhA). (patentsencyclopedia.com)
  • 13. The method of claim 1, wherein the recombinant host cell further expresses at least one protein selected from the group consisting of citrate synthase with reduced sensitivity to NADH and pyruvate dehydrogenase with reduced sensitivity to NADH. (patentsencyclopedia.com)
  • 105. The method of claim 102, wherein the administering comprises topical administration of the LFA-1 antagonist via a carrier vehicle selected from the group consisting of liquid drops, liquid wash, gel, ointment, spray, and liposome. (patentsencyclopedia.com)
  • 106. The method of claim 105, wherein the topical administration comprises infusion of the LFA-1 antagonist to an eye of the subject via a device selected from the group consisting of a pump-catheter system, a continuous or selective release system, and a contact lens. (patentsencyclopedia.com)
  • 4. The method of claim 1, wherein said compound known to bind to and convert said Bcl-B protein to an apoptotic form is selected from the group consisting of a peptide, peptide analog and small molecule. (patentsencyclopedia.com)
  • 10. The method of claim 1, wherein said fluorescence is measured by time-resolved fluorescence resonance energy transfer (TR-FRET), solid phase amplification (SPA) or an ELISA-like assay. (patentsencyclopedia.com)
  • 16. The method of claim 15, wherein said small molecule is selected from the group of molecules shown in Tables 5, 6, 7 and 8, or an analog thereof. (patentsencyclopedia.com)
  • 26. The composition of claim 24, wherein said detergent composition is selected from the group consisting of a laundry detergent, a fabric softening detergent, a dishwashing detergent, and a hard-surface cleaning detergent. (patentsencyclopedia.com)
  • gene
  • 8. The recombinant solventogenic organism of claim 1, comprising increased expression of a gene selected from the group consisting of Adh, Bcd, and Buk, a homolog thereof, or a variant thereof, relative to the organism strain prior to its transformation. (patentsencyclopedia.com)
  • 18. The recombinant solventogenic organism of claim 1, comprising increased expression of a gene selected from the group consisting of CheA, CheC, and CheD, a homolog thereof, or a variant thereof, relative to the organism strain prior to its transformation. (patentsencyclopedia.com)
  • 19. The recombinant solventogenic organism of claim 1, comprising decreased expression of a gene selected from the group consisting of ManIIAB and ManIIC, a homolog thereof, or a variant thereof, relative to the organism strain prior to its transformation. (patentsencyclopedia.com)
  • We strongly encourage the development of nomenclature schemes using a "stem" (or "root") symbol for members of a gene family or grouping, with a hierarchical numbering system to distinguish the individual members. (genenames.org)
  • To avoid confusion, the HGNC approved stem symbols are highlighted in bold (within red brackets) and the approved HGNC Gene Family groups without a common "stem" symbol are also highlighted in bold , both are linked to the Nomenclature Database . (genenames.org)
  • contains
  • This list contains a list of EC numbers for the third group, EC 3, hydrolases, placed in numerical order as determined by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology. (wikipedia.org)